BCAX vs O · $1.51B cap vs P/E 50, rev $5.27B
Bicara Therapeutics Inc. Common Stock (BCAX) versus Realty Income Corporation (O) — a side-by-side from cached financials, not a winner call.
Bicara Therapeutics Inc. Common Stock (BCAX) is a biotechnology company listed on NASDAQ.
Realty Income Corporation (O) is a reit - retail company listed on NYSE.
BCAX does not have a complete income-statement cache yet.
Latest reported O revenue for 2024-12-31 was $5.27B. Net income was $867.3M. Revenue was up 29.2% from 2023-12-31 to 2024-12-31. O currently screens at market cap $56.48B and trailing P/E 49.6.
BCAX currently screens at market cap $1.51B. O currently screens at market cap $56.48B and trailing P/E 49.6.
Not investment advice. Open the BCAX and O stock pages for the full models.
Not investment advice.